For those diagnosed with mesothelioma, an asbestos-related cancer of the lining of the lung (pleura) or the lining of the abdominal cavity (peritoneum), finding a credible source of information about the disease itself and the medical options available, is of the highest priority. After years of research and synthesis of information, we have assembled a web site and packet for patients and their loved ones. We hope you find this web site helpful.
A be overwhelming, and we are here to answer any questions you might have, and to help you take the steps necessary to find the options that are best suited to your individual needs.
Our staff is experienced and knowledgeable in dealing with mesothelioma patients and their family members, and the service we provide is always with appreciation for the difficult time you are facing. Although you have found us on the Internet, rest assured there are real people here to help. Please feel free to contact us at any time at 1-877-FOR-MESO (367-6376). (Please read disclaimer at bottom of page before proceeding.)
HOPE
"Hope is the companion of power, and the mother of success; for who so hopes strongly, has within him the gift of miracles." -- Samuel Smiles
This segment begins with more information about the causes of the disease and characteristic symptoms. Our comprehensive section on discusses surgery, chemotherapy, and radiation therapy as well as new types under investigation. We discuss ways to treat mesothelioma and some advice on choosing your doctor . The segment details current clinical studies and links to information specific to those trials.
SUPPORT
"Too often we understimate the power of a touch, a smile, a kind word, a listening ear, an honest compliment, or the smallest act of caring, all of which have the potential to turn a life around." --Dr. Leo Buscaglia
Start planning with , how to find places to stay near treatment facilities and how to get there in the section. Relevant and are updated regularly. Our SUPPORT segment ends with who have uplifting stories to tell.
No comments:
Post a Comment